By: Benzinga
Benzinga's M&A Chatter for Wednesday March 20, 2013
The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday March 20, 2013: Valeant Pharmaceuticals to Acquire Obagi Medical Products for $19.75/Share in Cash The Deal:Valeant Pharmaceuticals (NYSE: VRX ) announced Wednesday that it has entered into a definitive agreement under which Valeant will acquire all
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here